https://www.biospace.com/ym-biosciences-reports-additional-results-from-nimotuzumab-phase-iii-study
YM BioSciences Reports Additional Results from NIMOTUZUMAB PHASE III Study - BioSpace
phase iii studyym biosciencesadditional resultsreports
https://www.finanznachrichten.de/nachrichten-2026-05/68424410-cabral-gold-inc-cabral-gold-announces-additional-results-of-infill-drilling-at-the-mg-gold-deposit-cuiu-cuiu-gold-district-brazil-doubles-number-296.htm
Cabral Gold Inc.: Cabral Gold Announces Additional Results of Infill Drilling at the MG Gold...
Vancouver, British Columbia--(Newsfile Corp. - May 7, 2026) - Cabral Gold Inc. (TSXV: CBR) (OTCQX: CBGZF) ("Cabral" or the "Company") is pleased to announce...
cabral goldadditional results
https://www.barchart.com/story/news/1110857/1911-gold-reports-additional-results-from-underground-delineation-drilling-at-true-north
1911 Gold Reports Additional Results from Underground Delineation Drilling at True North
VANCOUVER, BC , April 2, 2026 /CNW/ - 1911 Gold Corporation (" 1911 Gold " or the " Company ") (TSXV: AUMB) (OTCQX: AUMBF) (FRA: 2KY) is pleased to provide...
gold reportsadditional results
https://investingnews.com/bold-ventures-announces-additional-results-from-drilling-at-burchell/
Bold Ventures Announces Additional Results from Drilling at Burchell | INN
May 7, 2026 - Bold Ventures Inc. (TSXV: BOL,OTC:BVLDF) (the "Company" or "Bold") is pleased to announce the results from holes BL-26-03 and BL-26-04a from the first phase of...
bold venturesadditional resultsannouncesdrillingburchell
https://www.rba.gov.au/publications/rdp/2022/2022-04/appendix-d.html
Appendix D: Additional Empirical Results | RDP 2022-04: The Unit-effect Normalisation in...
https://www.biospace.com/madrigal-announces-additional-positive-results-from-the-pivotal-phase-3-maestro-nash-clinical-trial-of-resmetirom-for-the-treatment-of-nash-with-liver-fibrosis
Madrigal Announces Additional Positive Results from the Pivotal Phase 3 MAESTRO-NASH Clinical Trial...
Jan 6, 2023 - Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH),...
https://www.newsfilecorp.com/release/83545/Glow-LifeTech-Reports-on-Additional-Research-Results-on-ArtemiC-and-Positive-Implications-for-COVID19-Variants
Glow LifeTech Reports on Additional Research Results on ArtemiC and Positive Implications for...
Toronto, Ontario--(Newsfile Corp. - May 11, 2021) - Glow LifeTech Corp. (CSE: GLOW) (FSE: 9DO) ("Glow" or the "Company"), a...
additional research